Management of intracranial tuberculous mass lesions: how long should we treat for? (2019)
Attributed to:
STEROID PROTECTION FROM TUBERCULOSIS-ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.15501.2
PubMed Identifier: 32047859
Publication URI: http://europepmc.org/abstract/MED/32047859
Type: Journal Article/Review
Volume: 4
Parent Publication: Wellcome open research
ISSN: 2398-502X